(Q44773162)

6 December 2017

title

Terbinafine in onychomycosis of the toenail: a novel treatment protocol (English)

1 reference

6 December 2017

Terbinafine in onychomycosis of the toenail: A novel treatment protocol (English)

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

1 June 2024

0 references

A. Watson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593777

1 June 2024

J. Marley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593777

1 June 2024

D. Ellis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593777

1 June 2024

T. Williams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593777

1 June 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

full work available at URL

6 December 2017

https://api.elsevier.com/content/article/PII:0190962295918159?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

https://api.elsevier.com/content/article/PII:0190962295918159?httpAccept=text/plain

1 June 2024

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Journal of the American Academy of Dermatology

1 June 2024

published in

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

5 Pt 1

1 reference

6 December 2017

page(s)

775-779

1 reference

Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey

6 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

The epidemiology of onychomycosis in Britain.

1 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Mycology of nail disorders

1 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Oral therapeutic agents in fungal nail disease

1 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Ketoconazole-induced fulminant hepatitis necessitating liver transplantation

1 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

In-vitro studies with SF 86-327, a new orally active allylamine derivative.

1 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

1 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

A randomized treatment duration-finding study of terbinafine in onychomycosis

1 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize

1 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

Special features of the clinical use of oral terbinafine in the treatment of fungal diseases

1 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91815-9

1 June 2024

Identifiers

1 reference

6 December 2017

1 reference